| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |